Programmable microparticles rewire CAR signaling to enable super-physiological expansion of human T cells in vitro
Qinghe Zeng, Landon Flemming, Yuanzhou CheniD, Thomas MazumderiD, Heinz HammerlindliD, Greg M. AlleniD, Ricardo AlmeidaiD, Jasper Z. WilliamsiD, Rogelio Antonio Hernández-LópeziD, Justin EyquemiD, Chun YeiD, Wendell A. LimiD, Qizhi TangiD, Tejal Ashwin DesaiiD, Xiao HuangiD
Abstract
T cell proliferative capacity and persistence critically determine the therapeutic success of chimeric antigen receptor (CAR) T cells. However, it remains unknown if and how human CAR-T cells can be externally programmed to reach maximal proliferative capacity. Here, we use programmable PLGA microparticles functionalized with CAR-antigens and CD28-costimulatory antibodies (CAREp) to repeatedly stimulate human CD8+ CAR-T cells in vitro. CAREp-stimulated CAR-T cells expanded continuously for over 100 days--versus [~]30 days with tumor cell stimulation--and achieved up to 1018-fold cumulative expansion, greatly surpassing CD3/28-Dynabeads. Early-phase transcriptomic responses-- upregulation of DNA repair, cell cycle, telomere maintenance, and mitochondrial pathways--aligned with long-term outcomes: massive proliferation, telomere stability, robust respiration, and preserved progenitor phenotype by single-cell sequencing. Differentiation and exhaustion signals were broadly suppressed. Transient telomerase activity further supported physiologic expansion. These findings demonstrate that nanoscale-controlled extracellular cues can rewire intracellular signaling to drive durable, super-physiological expansion of functional CAR-T cells.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy
Tao Zheng, Keerthana Ramanathan, … Sine Reker Hadrup·Nature CommunicationsPeer-reviewed·Jan 20, 2026
- Antigen-specific stimulation and expansion of CAR-T cells using membrane vesicles as target cell surrogates
V. M. Ukrainskaya, Y. P. Rubtsov, … R. A. Lerner·bioRxiv·Mar 18, 2021
- Functionalized microcarriers improve T cell manufacturing by facilitating migratory memory T cell production and increasing CD4/CD8 ratio
N. J. Dwarshuis, H. W. Song, … K. Roy·bioRxiv·May 23, 2019
- Beyond ex vivo and in vivo CAR T: antigen-driven CAR T (adCAR-T) expansion method enables rapid, physiological CAR T cells programming.
Andrey Samsonov·bioRxiv·May 18, 2026
- In vivo programming of stem-like CAR T cells by lymphatic-selective lipid nanoparticle enables durable anti-tumour efficacy in orthotopic model
- A Lymphomimetic Synthetic Immune Niche, Consisting of CCL21 and ICAM1, Accelerates the Expansion of Potent CAR T-cells
Karin Brezinger-Dayan, Sofi Yado, … Michal Judith Besser·bioRxiv·Sep 3, 2026